drugset / Trial / NCT00193388
Weekly Topotecan in the Second-Line Treatment of Small Cell Lung Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
In this phase II trial, we will evaluate the weekly schedule of topotecan in the second-line treatment of patients with small cell lung cancer
Timeline
- Start
- 2002-09
- Primary completion
- 2004-12
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Topotecan | Small molecule | — | — |